Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tremoulet

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
IJID Regions|September 19, 2024
Multisystem inflammatory syndrome in children across 16 Latin American countries: A multicenter study from the REKAMLATINA NetworkJimena García-Silva, Rolando Ulloa-Gutierrez, Gabriela Ivankovich-Escoto, et al.
Nature Communications|May 27, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
Med (New York, N.Y.)|August 19, 2023
Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signatureDominic Habgood-Coote, Clare Wilson, Chisato Shimizu, et al.
Nature Communications|August 12, 2022
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
Arthritis Care & Research|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
Contemporary Clinical Trials|March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Paediatrics & Child Health|December 1, 2025
The landscape of inter-institutional and multinational collaborations in Kawasaki diseaseRocio Gutierrez Rojas, Fabiola Breault, Raed Alzyoud, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2023
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional SignatureHeather R Jackson, Luca Miglietta, Dominic Habgood-Coote, et al.
Nature Medicine|February 12, 2019
Evaluation and accurate diagnoses of pediatric diseases using artificial intelligenceHuiying Liang, Brian Y Tsui, Hao Ni, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
IJID Regions|September 19, 2024
Multisystem inflammatory syndrome in children across 16 Latin American countries: A multicenter study from the REKAMLATINA NetworkJimena García-Silva, Rolando Ulloa-Gutierrez, Gabriela Ivankovich-Escoto, et al.
Nature Communications|May 27, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
Med (New York, N.Y.)|August 19, 2023
Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signatureDominic Habgood-Coote, Clare Wilson, Chisato Shimizu, et al.
Nature Communications|August 12, 2022
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
Arthritis Care & Research|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
Contemporary Clinical Trials|March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Paediatrics & Child Health|December 1, 2025
The landscape of inter-institutional and multinational collaborations in Kawasaki diseaseRocio Gutierrez Rojas, Fabiola Breault, Raed Alzyoud, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2023
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional SignatureHeather R Jackson, Luca Miglietta, Dominic Habgood-Coote, et al.
Nature Medicine|February 12, 2019
Evaluation and accurate diagnoses of pediatric diseases using artificial intelligenceHuiying Liang, Brian Y Tsui, Hao Ni, et al.
Pageof 29